Medical Treatment of Primary Canine Glaucoma

The Veterinary Clinics of North America. Small Animal Practice
Anthony F AlarioStefano Pizzirani

Abstract

Glaucoma is a painful and often blinding group of ocular diseases for which there is no cure. Although the definition of glaucoma is rapidly evolving, elevated intraocular pressure (IOP) remains the most consistent risk factor of glaucoma in the canine patient. Therapy should be aimed at neuroprotection. The mainstay of therapy focuses on reducing IOP and maintaining a visual and comfortable eye. This article discusses the most current ocular hypotensive agents, focusing on their basic pharmacology, efficacy at lowering IOP, and recommended use in the treatment of idiopathic canine glaucoma.

References

May 1, 1979·Survey of Ophthalmology·T J Zimmerman, W P Boger
Jan 1, 1993·Journal of Ocular Pharmacology·T J Zimmerman
Jan 1, 1994·Experimental Eye Research·J S SchumanJ A Nathanson
Feb 1, 1997·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T H MarenN S Levy
Jul 1, 1997·Survey of Ophthalmology·F BecquetO Goureau
Jul 31, 1998·Eye·A P Rotchford, K M Murphy
Apr 1, 1999·Nitric Oxide : Biology and Chemistry·J P BoisselU Förstermann
Apr 8, 1999·Experimental Eye Research·Y L WangM E Yablonski
Dec 30, 1999·Progress in Retinal and Eye Research·M F Sugrue
Sep 21, 2000·Journal of the American Animal Hospital Association·P E MillerM K Herrmann
Oct 20, 2000·American Journal of Veterinary Research·M E StuderJ Stiles
Jul 5, 2001·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·J C MillarW S Wilson
Feb 23, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hanna KotikoskiHeikki Vapaatalo
Feb 23, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yun-Liang WangCarol B Toris
Apr 10, 2002·Veterinary Ophthalmology·A Michelle WillisTerah E Robbin
Nov 26, 2002·Veterinary Ophthalmology·Kirk N Gelatt, Edward O MacKay
Jan 23, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kirk N Gelatt, Edward O Mackay
Feb 27, 2003·American Journal of Veterinary Research·Brian J SkorobohachDiane V H Hendrix
Jun 5, 2003·Nature Reviews. Molecular Cell Biology·Kirsi Riento, Anne J Ridley
Apr 28, 2004·The Veterinary Clinics of North America. Small Animal Practice·A Michelle Willis
Feb 25, 2006·Veterinary Ophthalmology·Alex B CarvalhoPatrícia R Silveira
Jul 6, 2006·The Journal of Veterinary Medical Science·Naoaki TakiyamaSigeo Ohba
Jul 4, 2007·Journal of the American Veterinary Medical Association·Daniel R BinderTobias Gerhard
Dec 7, 2007·Investigative Ophthalmology & Visual Science·Megumi HonjoMakoto Araie
Dec 17, 2008·Survey of Ophthalmology·Carol B TorisPaul L Kaufman
Feb 3, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Nikos N MarkomichelakisGerasimos Georgopoulos
Mar 31, 2009·Expert Opinion on Drug Delivery·Thirumurthy Velpandian
May 8, 2009·Expert Review of Medical Devices·Victoria R Kearns, Rachel L Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.